BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7147529)

  • 1. Urinary cholesterol in cancer screening.
    Jüngst D; Osterholzer M; Tauber R; Karl HJ
    Urology; 1982 Nov; 20(5):495-8. PubMed ID: 7147529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the clinical significance of nonesterified and total cholesterol in urine.
    Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
    Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of cholesterol excretion in the urine].
    Jüngst D; Osterholzer M; Lazik E; Karl HJ
    Acta Med Austriaca Suppl; 1979; 6():406-9. PubMed ID: 299242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholesterol and urinary tract diseases].
    Frick J; Spiteller G
    Z Urol Nephrol; 1968 Dec; 61(12):833-8. PubMed ID: 4183283
    [No Abstract]   [Full Text] [Related]  

  • 5. Is urinary cholesterol determination a possible screening test for urological carcinomas?
    Jüngst D; Tauber R; Osterholzer M; Karl HJ
    Urol Res; 1981; 9(1):1-3. PubMed ID: 7268998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia.
    Jüngst D; Tauber R; Lazik E; Karl HJ
    Urology; 1981 Jul; 18(1):65-7. PubMed ID: 6167049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary excretion of cholesterol in various diseases. (Especially in cancer of the urogenital system)].
    Spiteller-Friedmann M; Spiteller G; Spiteller H; Frick J
    Osterr Z Erforsch Bekampf Krebskr; 1971; 26(1):25-35. PubMed ID: 5171242
    [No Abstract]   [Full Text] [Related]  

  • 8. Asymptomatic microscopic hematuria.
    Golin AL; Howard RS
    J Urol; 1980 Sep; 124(3):389-91. PubMed ID: 7431504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
    Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
    Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group].
    Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
    Gan To Kagaku Ryoho; 1997 May; 24(7):837-42. PubMed ID: 9170522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary tract cancer screening through analysis of urinary red blood cell volume distribution.
    Wakui M; Shiigai T
    Int J Urol; 2000 Jul; 7(7):248-53. PubMed ID: 10910226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microscopic hematuria of postrenal origin].
    Graber P
    Schweiz Med Wochenschr; 1987 Dec; 117(50):1987-92. PubMed ID: 3433079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
    Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
    BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of asymptomatic microscopic hematuria in adults.
    Sharp VJ; Barnes KT; Erickson BA
    Am Fam Physician; 2013 Dec; 88(11):747-54. PubMed ID: 24364522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria.
    Samson P; Waingankar N; Shah P; Friedman D; Kavoussi L; Han J
    Urol Oncol; 2018 Jan; 36(1):10.e1-10.e6. PubMed ID: 28988782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients.
    Feifer AH; Steinberg J; Tanguay S; Aprikian AG; Brimo F; Kassouf W
    Urology; 2010 Jun; 75(6):1278-82. PubMed ID: 20138655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microhematuria in Postmenopausal Women: Adherence to Guidelines in a Tertiary Care Setting.
    Bradley MS; Willis-Gray MG; Amundsen CL; Siddiqui NY
    J Urol; 2016 Apr; 195(4 Pt 1):937-41. PubMed ID: 26523879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
    Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
    Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary mucoproteins. Clinical investigation in the diseases of the kidney and urinary tract].
    Saito H
    Nihon Hinyokika Gakkai Zasshi; 1972 Apr; 63(4):241-7. PubMed ID: 5065456
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of benign microscopic hematuria among women with interstitial cystitis: implications for evaluation of genitourinary malignancy.
    Stanford EJ; Mattox TF; Parsons JK; McMurphy C
    Urology; 2006 May; 67(5):946-9. PubMed ID: 16635517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.